Skip to main content Skip to navigation
Fixable Viability Stain 440UV

BD Horizon™ Fixable Viability Stain 440UV

(RUO)
Fixable Viability Stain 440UV
Flow cytometric analysis of human Jurkat cells stained with BD Horizon™ Fixable Viability Stain 440UV. Cells from the human Jurkat (Acute T cell leukemia, ATCC TIB-152) cell line were treated with 0.025% DMSO (Left Panels) or 5 μM camptothecin (Right Panels) for 16 hours and then stained (Bottom Panels) with BD Horizon™ Fixable Viability Stain 440UV (Cat. No. 566332) in serum-free buffer. The cells were then either left unfixed (solid line histograms) or fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655) and permeabilized in BD Phosflow™ Perm/Wash Buffer I (Cat. No. 557885) (dashed line histograms). Dead cell fluorescence is retained after fixation and permeabilization. The shift in the fluorescence of the live cells is due to a shift in auto-fluorescence post-fixation, as evidenced by the shift in the unstained (Top Panels) samples. Histograms were derived from gated events with the forward and side light-scattering characteristics of intact Jurkat cells. Flow cytometric analysis was performed using a BD LSRFortessa™ X-20 Flow Cytometry System. Please note that FVS440UV is also compatible with BD Phosflow™ Perm Buffer III (Cat. No.558050) or BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725).
Flow cytometric analysis of human Jurkat cells stained with BD Horizon™ Fixable Viability Stain 440UV. Cells from the human Jurkat (Acute T cell leukemia, ATCC TIB-152) cell line were treated with 0.025% DMSO (Left Panels) or 5 μM camptothecin (Right Panels) for 16 hours and then stained (Bottom Panels) with BD Horizon™ Fixable Viability Stain 440UV (Cat. No. 566332) in serum-free buffer. The cells were then either left unfixed (solid line histograms) or fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655) and permeabilized in BD Phosflow™ Perm/Wash Buffer I (Cat. No. 557885) (dashed line histograms). Dead cell fluorescence is retained after fixation and permeabilization. The shift in the fluorescence of the live cells is due to a shift in auto-fluorescence post-fixation, as evidenced by the shift in the unstained (Top Panels) samples. Histograms were derived from gated events with the forward and side light-scattering characteristics of intact Jurkat cells. Flow cytometric analysis was performed using a BD LSRFortessa™ X-20 Flow Cytometry System. Please note that FVS440UV is also compatible with BD Phosflow™ Perm Buffer III (Cat. No.558050) or BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725).
Product Details
Down Arrow Up Arrow


BD Horizon™
Flow cytometry, Intracellular staining (flow cytometry) (Tested During Development)
AB_2869748
RUO


Recommended Assay Procedures

Preparation

Bring FVS440UV dye powder and 363 μl of fresh cell culture-grade Dimethyl Sulfoxide (DMSO; eg, Sigma D2650) to room temperature. Add 363 μl of DMSO and vortex solution well. Inspect the solution and repeat vortex until the stock dye has fully dissolved. This is the Stock Solution.

Storage

Upon arrival, store the dry dye desiccated and protected from light at -80°C until use. After reconstitution with DMSO, store the Stock Solution at -20°C in small aliquots. Do not use reconstituted dye after 90 days of storage. Please discard the dye solution after 90 days post reconstitution with DMSO.

Cytometry Requirements

UV laser-equipped Flow Cytometers (eg, BD LSRFortessa™, BD LSRFortessa™ X-20, or BD™ LSR II) can be used. This dye can be read out of filters commonly used for DAPI or Hoechst dyes (eg, 450/50). This dye is also compatible with filter sets intended for BD Horizon™ BUV395 (eg, 379/28), though more dye may need to be used to achieve the same resolution. See "Procedure" for more information.

Fluorescence compensation is best achieved using a sample of the cells of interest stained with FVS440UV. When designing multicolor panels, please be aware of spillover into the BD Horizon™ BV421 and APC channels. Panels should be optimized to take this spillover into account. We recommend titrating the dye and using the lowest possible concentration that provides adequate resolution of live and dead populations for the cell type of interest to reduce spillover.

Procedure

Fixable Viability Stain 440UV labeling of cells

1.        Prepare cells for flow cytometry staining using sodium azide-free buffers.

2.        Wash cells one time in sodium azide- and protein-free Dulbecco's Phosphate Buffered Saline (1× DPBS).

3.        Resuspend cells at 1-10 × 10^6 cells/ml in sodium azide- and protein-free 1× DPBS.

4.        Add 1 µl of BD Horizon™ Fixable Viability Stain 440UV Stock Solution for each 1 ml of cell suspension (1:1000) and vortex immediately.

a.        Note: We recommend titrating the dye for optimal performance, as different cell types and different applications can result in a wide degree of variability in staining.

b.        Note: If the dye is to be analyzed using a BD Horizon BUV395 filter set (eg, 379/28 bandpass filter), we recommend using at least 2-4 µl per 1 ml of cell suspension as a starting point for titration.

5.        Incubate the mixture for 10-15 minutes at room temperature protected from light.

a.        Optional: Alternatively, incubate mixtures at 37°C for 5-7 minutes or 2-8°C for 30-60 minutes.

6.        Wash cells twice with 2 ml of BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) or the equivalent.

7.        Decant the supernatant and gently mix to disrupt the cell pellet.

8.        Resuspend the cells in Stain Buffer (FBS) or equivalent.

9.        Stain, fix and permeabilize cells as desired for downstream applications.

Notes:

1.        Each user should determine the optimal concentrations of reagents, cells, and conditions for the assay of interest. We recommend titrating the reagent in early experiments to obtain optimal results.

2.        The reactivity of the free dye is quenched by washing with buffer containing protein (eg, FBS or BSA).

3.        Cells may be stained in bulk prior to freezing or staining with fluorescent antibodies.

4.        BD Horizon™ Fixable Viability Stain 440UV can be used in intracellular staining assays that require fixation with formaldehyde and permeabilization with methanol and detergents such as those used for BD Phosflow™ staining (eg, BD Phosflow™ Perm Buffer III, Cat. No. 558050), intracellular cytokine staining (eg, BD Cytofix/Cytoperm™ Fixation/Permeablization Kit, Cat. No. 554714), or transcription factor staining (eg, BD Pharmingen™ Transcription Factor Buffer Set, Cat. No. 562574).

5.        Apoptotic cells can show variable staining. We recommend co-staining with, eg, Annexin V FITC (Cat. No. 556419) or Alexa Fluor® 647 Rabbit Anti-Active Caspase-3 (Cat. No. 560626) if further analysis is desired for the apoptotic cells.

Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
  3. Before staining with this reagent, please confirm that your flow cytometer is capable of exciting the fluorochrome and discriminating the resulting fluorescence.
  4. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
566332 Rev. 1
Antibody Details
Down Arrow Up Arrow

BD Horizon™ Fixable Viability Stain 440UV (FVS440UV) is useful for discrimination of viable from non-viable mammalian cells in multicolor flow cytometric applications. This dye reacts with and covalently binds to cell-surface and intracellular amines. Permeable plasma cell membranes, such as those present in necrotic cells, allow for the intracellular diffusion of the dye and covalent binding to higher overall concentrations of amines than in non-permeable live cells. Therefore, necrotic cells present in a typical in vitro assay label with higher levels of dye increasing their fluorescence intensity 10-20 fold over that of viable cells. The labeled cells can be fixed with formaldehyde for downstream decontamination, freezing and/or permeabilization and subsequent intracellular staining while maintaining stable viability stain fluorescence.

BD Horizon™ Fixable Viability Stain 440UV is excited by the UV laser (with an excitation maximum of 338 nm), and has a fluorescence emission maximum of 436 nm.

Danger: Hazard statement - Causes serious eye damage.

Precautionary statements - Wear eye protection / face protection. Wash thoroughly after handling.

IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor.

566332 Rev. 1
Citations & References
Down Arrow Up Arrow

Development References (5)

  1. Abrams B, Diwu Z, Guryev O, et al. 3-Carboxy-6-chloro-7-hydroxycoumarin: a highly fluorescent, water-soluble violet-excitable dye for cell analysis. Anal Biochem. 2009; 386(2):262-269. (Methodology). View Reference
  2. Burmeister Y, Lischke T, Dahler AC, et al. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol. 2008; 180(2):774-782. (Methodology). View Reference
  3. Charles ED, Green RM, Marukian S, et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood. 2008; 111(3):1344-1356. (Methodology). View Reference
  4. Perfetto SP, Chattopadhyay PK, Lamoreaux L, et al. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J Immunol Methods. 2006; 313(1–2):199-208. (Methodology). View Reference
  5. Perfetto SP, Chattopadhyay PK, Lamoreaux L, et al. Amine-reactive dyes for dead cell discrimination in fixed samples. Curr Protoc Cytom. 9(9.34)(Methodology). View Reference
View All (5) View Less
566332 Rev. 1

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.